The DHDDS gene helps cells make dolichol, a substance needed to attach sugar tags to proteins so they fold and work properly. If the gene does not work well, some proteins are not processed correctly, which can affect the eyes, brain, and other organs. This gene plays an important role in tissues that need steady cell maintenance, especially the retina at the back of the eye. Pathogenic variants in the DHDDS gene are linked to inherited vision loss and, in some people, developmental delay, seizures, or movement problems.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mostly guide when certain processes happen, where they occur, and how strongly they operate. As a group, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, and medications. If you want to look into this subject more closely, you can find more in the LearnHub.
Overview
DHDDSGene function
What if the gene works
The DHDDS gene helps cells make dolichol, a fatty carrier used to add sugar chains to proteins. This supports normal protein folding, transport, and function throughout the body.
Risk
What if the gene does not work
Variants in the DHDDS gene can range from milder changes that mainly cause inherited retinal degeneration with progressive vision loss to more severe variants linked to developmental delay, seizures, and movement problems.
Treatment
What does that mean for your treatment
No DHDDS-specific treatment or drug-selection approach is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant in the DHDDS gene.
Conditions associated with DHDDS
Gene function
What if the gene works
Your cells use the DHDDS gene to support one of the routine steps in preparing proteins for daily use. It helps build a lipid carrier called dolichol, which ferries sugar pieces inside the cell’s protein processing area. Understanding how the DHDDS gene works helps explain how many proteins are finished, folded, and moved to the right place.
The DHDDS gene helps make dolichol, a fatty carrier molecule used inside cells. It builds the long chain that lets this carrier hold and deliver sugar building blocks where they are needed.
Cells use dolichol to attach sugar chains to many newly made proteins in the endoplasmic reticulum (the cell’s protein processing area). This step, called glycosylation (adding sugars to proteins), is part of normal protein finishing.
When proteins receive the right sugar chains, they can fold into the right shape and travel to the correct place. This supports routine cell communication, cell surface structure, and steady daily function.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and form part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DHDDS gene can alter enzyme shape or stability, lowering how well cells make dolichol, a molecule needed for protein glycosylation (a finishing step many proteins need). Some DHDDS gene variants cause only a partial drop in activity, while more disruptive variants can greatly weaken the enzyme or keep it from working with its partner protein. This range helps explain why DHDDS gene variants and retinal disease may be milder in some people and broader in others.
How variants are linked to conditions
Pathogenic variants in the DHDDS gene can cause a small number of rare inherited conditions. The best established DHDDS gene conditions include retinitis pigmentosa, which often starts with trouble seeing in dim light and loss of side vision, and DHDDS-congenital disorder of glycosylation, which can include developmental delay, seizures, movement problems, and vision changes. The exact diagnosis usually depends on the specific variant pattern a person carries.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks linked to the DHDDS gene. In most known DHDDS-related conditions, risk is mainly shaped by the specific gene change inherited in a family, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of DHDDS variants
DHDDS-related conditions are inherited in an autosomal recessive pattern. In plain terms, how DHDDS gene variants are inherited usually means a person has to receive one altered copy of the DHDDS gene from each parent to be affected. Parents who each carry one variant are often unaffected themselves, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. This pattern applies equally to sons and daughters.
What does my DHDDS result mean for my family?
DHDDS results can have different meaning for relatives because this gene is linked to more than one inherited condition. In some families, both parents may be healthy carriers, so siblings could also be affected or be carriers; in others, a single changed copy can be enough to cause the condition, so a parent, child, brother, or sister may also carry it. What it means for your family depends on the exact DHDDS result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the DHDDS gene reads the DNA in a blood or saliva sample, often through an inherited retinal disease panel or a broader sequencing test. It can show whether you carry a variant linked to a genetic condition and may help clarify whether the result is diagnostic, uncertain, or not considered harmful.
When should I consider getting a genetic test?
Consider testing for DHDDS if there is inherited vision loss in you or your family, especially retinitis pigmentosa, which causes trouble seeing at night and gradual narrowing of side vision. Testing may also be considered in children with developmental delay, seizures, or movement problems when doctors suspect a rare genetic cause.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they reveal varies depending on the condition and the kind of variant involved. Over time, the body is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas such as medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly than others, which can change how well a treatment works or how likely side effects are. This kind of difference is common and helps explain why the same medication can feel very effective for one person but less helpful or harder to tolerate for another.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way medications work in different people. By studying links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed and more personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the DHDDS gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work. If you have concerns about a medicine, side effects, or a treatment change, talk with your doctor or pharmacist.
History
The DHDDS gene first drew scientific attention through research on how cells make dolichol, a lipid needed to process many proteins correctly. From these first observations, research expanded steadily. In the early 2000s, scientists clarified that DHDDS works with a partner protein in this pathway, which helped place it within a broader map of inherited metabolic and eye conditions. A major milestone came in 2011, when variants in the DHDDS gene were linked to a form of inherited retinal disease in people of Ashkenazi Jewish ancestry. Later studies connected other DHDDS variants with a wider range of neurologic and developmental conditions, deepening medical understanding of this gene’s clinical relevance.